Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds BMO Capital Downgrades Horizon Therapeutics to Market Perform

BMO Capital Downgrades Horizon Therapeutics to Market Perform

BMO Capital analyst Gary Nachman downgrades Horizon Therapeutics (NASDAQ:HZNP) from Outperform to Market Perform.

December 13, 2022

1 minute read

BMO Capital analyst Gary Nachman downgrades Horizon Therapeutics (NASDAQ:HZNP) from Outperform to Market Perform.

Canaccord Genuity Assumes LSI Industries at Buy, Announces Price Target of $9

October 21, 9:20 AM

Canaccord Genuity analyst George Gianarikas assumes LSI Industries (NASDAQ:LYTS) with a Buy rating and announces Price Target of $9.

August 31, 8:31 AM

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

September 20, 1:02 PM

Azul SA (NYSE: AZUL) joined other stocks making big moves on Wednesday.

May 16, 1:00 PM

LSB Industries (NYSE:LXU) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…